Denbrayce
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Denbrayce, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: EMA Authorised: Denbrayce (denosumab) — Mabxience Research SL
1 regulatory and trial event tracked for Denbrayce, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: EMA Authorised: Denbrayce (denosumab) — Mabxience Research SL